We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$82.5B
AUM Growth
+$5.26B
(+6.8%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-2.45%
Top 10 Holdings %
Top 10 Hldgs %
38.94%
Holding
962
New
129
Increased
342
Reduced
292
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$429M |
| 2 |
Airbnb
ABNB
|
+$235M |
| 3 |
T-Mobile US
TMUS
|
+$156M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$139M |
| 5 |
CRISPR Therapeutics
CRSP
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deere & Co
DE
|
+$488M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$222M |
| 3 |
Expeditors International
EXPD
|
+$191M |
| 4 |
Qualcomm
QCOM
|
+$187M |
| 5 |
CERN
Cerner Corp
CERN
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.12% |
| 2 | Consumer Discretionary | 15.99% |
| 3 | Communication Services | 13.72% |
| 4 | Healthcare | 12.84% |
| 5 | Industrials | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
SouthState Bank Corp
SSB
$10.5B
| $13M | 0.02% |
159,241
-724
| -0.5% | -$61.6K |
|
352
BorgWarner
BWA
$13.9B
| $12.7M | 0.02% |
297,735
+12,179
| +4% | +$536K |
|
353
Viavi Solutions
VIAV
$9.66B
| $12.7M | 0.02% |
718,877
-20,564
| -3% | -$347K |
|
354
Cemex
CX
$16.3B
| $12.7M | 0.02% |
1,507,632
| – | – |
|
355
APi Group
APG
$18B
| $12.5M | 0.02% |
+897,300
| New | +$12.7M |
|
356
Packaging Corp of America
PKG
$22.8B
| $12.5M | 0.02% |
92,035
+3,128
| +4% | +$450K |
|
357
PROG Holdings
PRG
$1.71B
| $12.4M | 0.02% |
256,903
+69,686
| +37% | +$3.47M |
|
|
CADE
358
DELISTED
Cadence Bank
CADE
| $12.3M | 0.01% |
432,990
+4,234
| +1% | +$128K |
|
359
Federal Agricultural Mortgage
AGM
$2.56B
| $12.2M | 0.01% |
122,868
-1,313
| -1% | -$133K |
|
360
KB Home
KBH
$3.59B
| $11.9M | 0.01% |
293,259
+35,539
| +14% | +$1.64M |
|
361
Cannae Holdings
CNNE
$649M
| $11.7M | 0.01% |
345,477
-6,234
| -2% | -$232K |
|
|
SGI
362
Somnigroup International
SGI
$13.7B
| $11.7M | 0.01% |
+298,042
| New | +$11.4M |
|
363
Cabot Corp
CBT
$4.52B
| $11.5M | 0.01% |
202,577
-950
| -0.5% | -$55.8K |
|
|
FREE
364
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $11.4M | 0.01% |
783,664
+162,653
| +26% | +$2.17M |
|
365
OceanFirst Financial
OCFC
$1.91B
| $11.3M | 0.01% |
542,012
-39,788
| -7% | -$891K |
|
366
Lantheus
LNTH
$6.59B
| $11.2M | 0.01% |
406,933
-3,982
| -1% | -$91.4K |
|
367
Miller Industries
MLR
$619M
| $11.2M | 0.01% |
284,757
+19,134
| +7% | +$816K |
|
|
QVCGA
368
DELISTED
QVC Group Inc Series A
QVCGA
| $11.2M | 0.01% |
17,037
+2,639
| +18% | +$1.69M |
|
369
Post Holdings
POST
$3.57B
| $11.1M | 0.01% |
156,227
+9,831
| +7% | +$725K |
|
370
John Wiley & Sons Class A
WLY
$2.66B
| $10.3M | 0.01% |
171,240
-773
| -0.4% | -$46K |
|
371
Atkore
ATKR
$3.16B
| $10.3M | 0.01% |
144,979
+28,199
| +24% | +$2.15M |
|
372
CVB Financial
CVBF
$3.99B
| $10.3M | 0.01% |
499,413
-36,644
| -7% | -$800K |
|
373
Quanex
NX
$1.01B
| $10.2M | 0.01% |
408,628
+3,182
| +0.8% | +$84.8K |
|
|
ACBI
374
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $10M | 0.01% |
394,333
+102,230
| +35% | +$2.7M |
|
375
BWX Technologies
BWXT
$15.6B
| $9.93M | 0.01% |
170,793
-3,101
| -2% | -$199K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2021 Portfolio in Review
As of Q2 2021, Loomis, Sayles & Company held 962 positions worth $82.5B, up 6.8% from $77.2B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Loomis, Sayles & Company's Q2 2021 filing shows 129 new, 342 increased, 292 reduced and 136 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 946,065 shares worth $160M. The largest sale was Deere & Co, an estimated $488M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q2 2021 buy was Alnylam Pharmaceuticals: 946,065 shares worth $160M.
- Loomis, Sayles & Company added most to Vertex Pharmaceuticals in Q2 2021, an estimated $429M increase.
- Loomis, Sayles & Company's biggest Q2 2021 reduction was Deere & Co, cutting an estimated $488M.
- Loomis, Sayles & Company fully exited Goosehead Insurance in Q2 2021, selling an estimated $66.6M.
- Loomis, Sayles & Company's ten largest holdings make up 39% of its $82.5B portfolio in Q2 2021.
- Loomis, Sayles & Company opened 129 new positions and closed 136 in Q2 2021.
- Loomis, Sayles & Company's portfolio value rose 6.8% quarter-over-quarter to $82.5B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2021, filed 13 Aug 2021.